MAP2K5 and breast carcinoma: Specifically, the MEK5/ERK5 pathway has emerged as apromising novel therapeutic target for breast cancer, as this signaling pathway regulatesprocesses integral to breast cancer, including initiation, progression, metastasis, and drugresistance.